ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,606 Cr | ₹2,949 Cr | ₹2,477 Cr | ₹2,105 Cr | ₹1,726 Cr |
What is the latest Total Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,606 Cr |
| Mar2025 | ₹2,949 Cr |
| Mar2024 | ₹2,477 Cr |
| Mar2023 | ₹2,105 Cr |
| Mar2022 | ₹1,726 Cr |
How is Total Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,606 Cr | 22.29 | |
| Mar2025 | ₹2,949 Cr | 19.05 | |
| Mar2024 | ₹2,477 Cr | 17.68 | |
| Mar2023 | ₹2,105 Cr | 21.94 | |
| Mar2022 | ₹1,726 Cr | - | |
Compare Total Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹43,212.8 Cr | 0.5% | 0.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 0.5% |
0.7% |
|
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses